Molecular response to imatinib mesylate of Brazilian patients with chronic myeloid leukemia

by Ana Lucia Vieira-Mion, Noemi Farah Pereira, Vaneuza Araujo Moreira Funke, Ricardo Pasquini

Late chimerical status after bone marrow transplantation in severe aplastic anemia according to two different preparatory regimens

by Marcia Quiroga, Noemi Farah Pereira, Marco Antonio Bitencourt, Carmem Bonfim, Marianna Gendre de Mesquita Monteiro, Ricardo Pasquini
Published 2018-04-01

Mutations in the breakpoint cluster region-Abelson murine leukemia 1 gene in Brazilian patients with chronic myeloid leukemia

by Heloísa Zorzi Costa, Noemi Farah Pereira, Luciane kaminski, Ricardo Pasquini, Vaneuza Araujo Moreira Funke, Ana Lucia Vieira Mion
Published 2018-10-01

Investigation of MHC gamma block C4A and C4B polymorphisms in unrelated hematopoietic stem cell transplantation

by Joselito Getz, Monica Goldenstein, Carmem Bonfim, Vaneuza Moreira Funke, Vergílio Colturato, Nelson Hamerschlak, Margareth Torres, David Sayer, Angelica Boldt, Ricardo Pasquini, Noemi Farah Pereira
Published 2020-07-01

Monitoring of BCR-ABL levels in chronic myeloid leukemia patients treated with imatinib in the chronic phase: the importance of a major molecular response

by Melissa Pereira Machado, Juarez Pires Tomaz, Irene Lorand-Metze, Cármino Antonio de Souza, Afonso Celso Vigorito, Marcia Torresan Delamain, Israel Bendit, Noemi Farah Pereira, Katia Borgia Barbosa Pagnano
Published 2011-06-01